The prohibition of thalidomide for the erythema nodosum leprosum
DOI:
https://doi.org/10.47878/hi.2000.v25.36432Abstract
.
Downloads
Download data is not yet available.
References
1 . BA RBA RUBIO, J ; FRANCO GONZA LE Z, E L u p u s eritematosos discoide y talidomida. Dermatologia - Rev. Mex., v.19, p.131, 1975.
2. BARNHILL, R.L.; McDOUGALL, A.C. Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J. Amer. Acad. DermatoL, v.7, p.317-323, 1982.
3. GRINSPAN, D. Significant response of oral aphthosis to thalidomide treatment. J. Amer. Acad. DermatoL, v.12, p.85-90, 1985.
4. GROSSHANS, E.; ILLY, G. Thalidomide therapy for inflammatory dermatoses. Int. J. DermatoL, v.23, p.598602, 1984.
5. HASPER, M. Chronic cutaneous lupus erythematosus: thalidomide treatment of 11 patients. Arch. DermatoL, v.119, p.812-815, 1983.
6. MARWICK, C. A talidomida está de volta - sob rígido controle. JAMA, v.2, n.2, p.290, 1998.
7. PENNA, GO, PINHEIRO, A.M.C., HAJJAR, L.A. Talidomida: mecanismo de ação, efeitos colaterais e uso terapêutico. An. bras. Dermatol., v.73, n.6, p.501-514, 1998.
8. PROENÇA, N.G. Emprego de talidomida em dermatologia. An. bras. DermatoL, v.70, n.1, p.61-67, 1995.
9. RUSTIN, M.H.A.; GILKES, J.J.H.; ROBINSON, T.W.E. Pyoderma gangrenosum associated with Behçet's disease: treatment with thalidomide. J. Amer. Acad. DermatoL, v.23, p.941-943, 1990.
10. SHESKIN, J. Thalidomide in the treatment of lepra reactions. Clin. PharmacoL Ther., v.6, p.303, 1965.
11. THOMPSON, C. Thalidomide effective for AIDS related oral ulcers (news). Lancet, v.346, p.1289, 1995.
12. VAN DEN BROECK, H. Treatment of prurigo nodularis with thalidomide. Arch. Dermatol, v.116, p.571-572, 1980
2. BARNHILL, R.L.; McDOUGALL, A.C. Thalidomide: use and possible mode of action in reactional lepromatous leprosy and in various other conditions. J. Amer. Acad. DermatoL, v.7, p.317-323, 1982.
3. GRINSPAN, D. Significant response of oral aphthosis to thalidomide treatment. J. Amer. Acad. DermatoL, v.12, p.85-90, 1985.
4. GROSSHANS, E.; ILLY, G. Thalidomide therapy for inflammatory dermatoses. Int. J. DermatoL, v.23, p.598602, 1984.
5. HASPER, M. Chronic cutaneous lupus erythematosus: thalidomide treatment of 11 patients. Arch. DermatoL, v.119, p.812-815, 1983.
6. MARWICK, C. A talidomida está de volta - sob rígido controle. JAMA, v.2, n.2, p.290, 1998.
7. PENNA, GO, PINHEIRO, A.M.C., HAJJAR, L.A. Talidomida: mecanismo de ação, efeitos colaterais e uso terapêutico. An. bras. Dermatol., v.73, n.6, p.501-514, 1998.
8. PROENÇA, N.G. Emprego de talidomida em dermatologia. An. bras. DermatoL, v.70, n.1, p.61-67, 1995.
9. RUSTIN, M.H.A.; GILKES, J.J.H.; ROBINSON, T.W.E. Pyoderma gangrenosum associated with Behçet's disease: treatment with thalidomide. J. Amer. Acad. DermatoL, v.23, p.941-943, 1990.
10. SHESKIN, J. Thalidomide in the treatment of lepra reactions. Clin. PharmacoL Ther., v.6, p.303, 1965.
11. THOMPSON, C. Thalidomide effective for AIDS related oral ulcers (news). Lancet, v.346, p.1289, 1995.
12. VAN DEN BROECK, H. Treatment of prurigo nodularis with thalidomide. Arch. Dermatol, v.116, p.571-572, 1980
Downloads
Published
2000-11-30
How to Cite
1.
Opromolla DVA. The prohibition of thalidomide for the erythema nodosum leprosum. Hansen. Int. [Internet]. 2000 Nov. 30 [cited 2024 Jul. 22];25(2):111-2. Available from: https://periodicos.saude.sp.gov.br/hansenologia/article/view/36432
Issue
Section
Editorial
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
This journal is licensed under a Creative Commons Attribution 4.0 International License.
